Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death

Mithilesh K. Das, Rajdeep Gaitonde, John M. Miller

Research output: Contribution to journalReview article

2 Scopus citations

Abstract

The implantable cardioverter defibrillator (ICD) is used for primary and secondary prophylaxis of sudden cardiac death in high-risk patients. Although several trials have demonstrated the superiority of ICD over standard medical therapy or antiarrhythmic medication in this population, a few trials have not shown survival benefit. This review examines the major ICD trials that provide the basis for current therapy in this rapidly changing and very important area of cardiology.

Original languageEnglish (US)
Pages (from-to)371-380
Number of pages10
JournalCurrent cardiology reports
Volume9
Issue number5
DOIs
StatePublished - Sep 1 2007

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Indications for implantable cardioverter defibrillator use for primary prevention of sudden cardiac death'. Together they form a unique fingerprint.

  • Cite this